Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Organogenesis Holdings (ORGO) Receivables - Net (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Receivables - Net data on record, last reported at $233.5 million in Q4 2025.

  • For Q4 2025, Receivables - Net rose 95.53% year-over-year to $233.5 million; the TTM value through Dec 2025 reached $233.5 million, up 95.53%, while the annual FY2025 figure was $233.5 million, 95.53% up from the prior year.
  • Receivables - Net reached $233.5 million in Q4 2025 per ORGO's latest filing, up from $182.2 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $233.5 million in Q4 2025 and bottomed at $72.0 million in Q1 2021.
  • Average Receivables - Net over 5 years is $106.6 million, with a median of $96.5 million recorded in 2023.
  • Peak YoY movement for Receivables - Net: skyrocketed 120.03% in 2021, then fell 8.33% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $82.5 million in 2021, then increased by 8.48% to $89.4 million in 2022, then dropped by 8.33% to $82.0 million in 2023, then soared by 45.66% to $119.4 million in 2024, then soared by 95.53% to $233.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $233.5 million in Q4 2025, $182.2 million in Q3 2025, and $131.5 million in Q2 2025.